Which Starter Dose Suits Your Side Effect Tolerance?
Mounjaro vs Wegovy Side Effects: Starting Dose Comparison
Understanding the side effects profile when comparing Mounjaro vs Wegovy starter doses helps you make an informed choice for your weight management journey. Wegovy begins with 0.25mg weekly for weeks 1-4, whilst Mounjaro starts at 2.5mg weekly for the same initial period. Both medications share similar gastrointestinal side effects including nausea, vomiting, diarrhoea, and constipation, but the intensity and frequency may vary due to their different mechanisms of action. Wegovy's semaglutide targets GLP-1 receptors exclusively, while Mounjaro's tirzepatide activates both GIP and GLP-1 receptors, potentially affecting how your body responds during the initial weeks.
The timing and severity of side effects when comparing Mounjaro vs Wegovy may differ significantly during your first month of treatment. Most patients experience the strongest side effects within 2-3 days of their weekly injection, with symptoms typically subsiding by day 5-6. Wegovy's lower starting dose of 0.25mg is specifically designed to minimise initial side effects, allowing your digestive system to gradually adapt to the medication. Clinical studies suggest that starting slowly with either medication reduces the likelihood of severe gastrointestinal symptoms that might cause treatment discontinuation.
Wegovy Starter Pricing and Bundle Options
Beginning your Wegovy journey costs £79.99 for the 0.25mg starter pen (weeks 1-4), with new customer discount code FIRST40 applied at checkout to reach this final price. For those planning ahead, our Intro Duo bundle combines 0.25mg and 0.5mg pens for £169.99, covering your first two months of treatment with convenient single-order delivery. The Intro Trio bundle (0.25mg, 0.5mg, and 1mg) provides three months of progressive dosing for £299.99, ensuring uninterrupted treatment progression. These bundles offer convenience rather than savings, providing Reliable Supply continuity and reducing the need for multiple orders during your crucial initial treatment period.
Returning customers can access the same Wegovy starter doses using discount code DOSE25 at checkout, maintaining consistent affordable access to treatment. The 16-week dose escalation schedule progresses from 0.25mg (£79.99) to 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), and finally 2.4mg maintenance dose (£209.99). Each dose level represents a carefully calibrated increase designed to maximise effectiveness whilst minimising side effects. Payment is processed securely through our GPhC-registered pharmacy (#9012878), ensuring full regulatory compliance and professional oversight.
Clinical Evidence for Mounjaro vs Wegovy Side Effects
The STEP clinical trials for Wegovy demonstrated that gastrointestinal side effects were most common during the initial dose escalation period, affecting approximately 44% of participants with nausea being the most frequently reported. In the pivotal STEP 1 trial (Wilding et al., NEJM, 2021), most side effects were mild to moderate and decreased over time as patients adapted to treatment. The gradual dose escalation protocol used in these trials forms the basis of the current prescribing guidelines for minimising side effects.
Mounjaro's SURMOUNT trials showed similar side effect profiles, though the dual receptor mechanism may produce different individual responses compared to Wegovy's single GLP-1 targeting approach. Both medications demonstrated that patients who successfully navigate the initial 8-12 weeks of treatment typically experience significant reduction in side effect severity. The prescription-only nature of both treatments ensures proper medical supervision during this critical adaptation period.
How Wegovy Works and Side Effect Development
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormones to reduce appetite and promote feelings of fullness after smaller meals. This mechanism works primarily in your brain's appetite control centres and throughout your digestive system, which explains why gastrointestinal side effects are most common initially. The medication slows gastric emptying, meaning food stays in your stomach longer, contributing to both the therapeutic effect and potential side effects like nausea or feeling overly full. As your digestive system adapts to this slower gastric emptying over several weeks, side effects typically diminish whilst the appetite-suppressing benefits remain. The once-weekly injection schedule using the FlexTouch pen device maintains steady medication levels, reducing the peak-and-trough effects that might exacerbate side effects with more frequent dosing. Understanding this mechanism helps patients recognise that initial side effects are often indicators that the medication is working as intended to alter appetite and digestion patterns.
EverydayMeds Ordering Process and Clinical Support
Starting Wegovy through EverydayMeds begins with a comprehensive 3-minute online clinical assessment covering your medical history, current medications, and weight management goals to ensure safe prescribing. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), evaluating your suitability for Wegovy and providing personalised guidance on managing potential side effects. Once approved, your Wegovy starter pen is dispatched via next-day delivery using specialised cold-chain packaging to maintain the 2-8°C temperature requirement throughout transit. Each delivery includes detailed administration instructions, side effect management guidance, and access to our clinical support team for ongoing questions. Our GPhC-registered pharmacy status (#9012878) ensures full regulatory compliance and professional oversight throughout your treatment journey. The entire process prioritises safety and support, particularly crucial during the initial weeks when side effects are most likely to occur.
Storage and Practical Considerations for Side Effect Management
Proper Wegovy storage at 2-8°C in your refrigerator is essential for maintaining medication potency and minimising injection site reactions that could compound other side effects. Once removed from refrigeration, Wegovy pens remain stable for up to 6 weeks at room temperature below 30°C, providing significant travel convenience compared to Mounjaro's 21-day room temperature limit. The FlexTouch pen device allows for precise dose delivery, and injecting at the same time each week helps maintain consistent medication levels that may reduce side effect variability. Taking your injection in the evening may help you sleep through the initial 2-3 hours when side effects are typically strongest after each dose. Never skip doses or attempt to accelerate the escalation schedule, as this mandatory gradual increase is specifically designed to minimise side effects whilst building therapeutic effectiveness. Keeping a side effect diary during your first 8 weeks can help you and your prescriber identify patterns and adjust timing or supportive measures as needed.
First-Time User Side Effect Expectations and Management
When comparing Mounjaro vs Wegovy side effects as a first-time user, expect the most noticeable symptoms during weeks 1-2 and again when transitioning to 0.5mg at week 5. Nausea typically peaks 2-4 hours after injection and may last 24-48 hours, often accompanied by reduced appetite that signals the medication is working effectively. Managing these initial side effects involves eating smaller, more frequent meals, avoiding fatty or spicy foods, and staying well-hydrated throughout the week. Some patients find that taking their injection before a lighter meal helps reduce nausea severity compared to injecting on an empty stomach.
The key difference in Mounjaro vs Wegovy side effects for new users often relates to individual tolerance for the different receptor mechanisms rather than absolute side effect severity. Both medications are available through EverydayMeds, and your prescriber can help determine which option aligns better with your medical history and side effect concerns. Starting with either medication requires patience and realistic expectations, as the first 4-8 weeks represent an adjustment period where side effects gradually diminish whilst therapeutic benefits increase. Most patients who successfully complete the initial dose escalation period report significant improvement in both side effect tolerance and weight management outcomes.
Begin Your Weight Management Journey with Confidence
Starting your weight management journey with either Wegovy or Mounjaro represents a significant commitment to long-term health improvement, supported by comprehensive clinical evidence and professional oversight. At EverydayMeds, new customers can access Wegovy 0.25mg starter pens from £79.99 using discount code FIRST40, whilst returning customers benefit from code DOSE25 for continued affordable access. Our streamlined ordering process, expert clinical support, and next-day cold-chain delivery ensure you have everything needed to manage potential side effects effectively during your crucial first weeks of treatment. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to recommend the most suitable option based on your individual medical profile and side effect tolerance. The prescription-only nature of these medications ensures proper medical supervision as you navigate the initial adjustment period and progress towards your weight management goals. Begin your assessment today at https://everydaymeds.co.uk/products/wegovy-0-25mg and take the first step towards sustainable weight management with professional clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
